AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:Â Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00….
SAMHSA Director: “The New Freedom Commission (NFC) report is not official Bush Administration policy, but rather the unofficial recommendations of an appointed commission.”
"Are we becoming patients for profit? That is the question knowledgeable observers are asking.
A report by the Drug Abuse Warning Network (DAWN), reveals some sobering facts about teenage suicide attempts that involve drugs.
The Arkansas Democrat Gazette reports (below): "TeenScreen, developed by a Columbia University professor, has come under intense criticism nationally."
Mental Screening ties to drug companies exposed. Screening for Mental Health (Harvard affiliated) received $500K from Eli Lillly. See: https://ahrp.org/children/mentalscreen/LillyCheck.jpg
TeenScreen hired high powered PR firms whose business is to create promotional campaigns to increase drug sales for its clients.
"More than 7 million americans are estimated to have misused stimulant drugs."
We are, however, very distressed at what appears to us to be a significant discrepancy between your statements and the reality of SAMHSA’s role in implementing the NFC report recommendations, as well as other discrepancies between your statements and SAMHSA’s actions.
